0001179110-20-002264.txt : 20200225 0001179110-20-002264.hdr.sgml : 20200225 20200225171428 ACCESSION NUMBER: 0001179110-20-002264 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200221 FILED AS OF DATE: 20200225 DATE AS OF CHANGE: 20200225 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Funck Robert E CENTRAL INDEX KEY: 0001565892 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 20652093 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD, AP6C-1N CITY: ABBOTT PARK STATE: IL ZIP: 60064-6092 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 2246676100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 4 1 edgar.xml FORM 4 - X0306 4 2020-02-21 0 0000001800 ABBOTT LABORATORIES ABT 0001565892 Funck Robert E 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-6400 0 1 0 0 Senior Vice President Common shares without par value 2020-02-21 4 A 0 25265 0 A 177438 D Common shares without par value 17570 I Profit Sharing Trust Common shares without par value 500 I By Daughter Common shares without par value 500 I By Daughter Option (right to buy) 87.72 2020-02-21 4 A 0 154013 0 A 2021-02-21 2030-02-20 Common shares 154013 154013 D These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes. Balance in the Abbott Laboratories Stock Retirement Trust as of February 21, 2020. The reporting person disclaims beneficial ownership of all securities held by his daughter. Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 51,337 on February 21, 2021, 51,338 on February 21, 2022, and 51,338 on February 21, 2023. Jessica H. Paik, Attorney-in-Fact for Robert E. Funck Jr. 2020-02-25